November 07, 2024 2 min read Save Anticoagulant therapy reduces risks for vision loss, stroke in giant cell arteritis Anticoagulant therapy reduces risks for vision loss, stroke in giant cell arteritis

2024-11-08 - 2024-11

Patients with giant cell arteritis who use anticoagulants demonstrate lower risks for vision loss, stroke and other cranial ischemic complications, according to data published in Annals of the Rheumatic Diseases.

ACCEL Lite: What Aspects of Cardiovascular Care are Most Primed for Disruption with AI?

2024-11-06 - 2024-11

Patients can benefit from better healthcare access and outcomes by services that are enabled by artificial intelligence (AI). The current state of technology is evolving to now allow diagnosis of advanced conditions from simple diagnostic testing, broadening the scope of early diagnosis and treatment.

Brochure Form

Abstracts enquiry

Registration enquiry

Contact Enquiry

Phone

WhatsApp

Useful Links

News

November 07, 2024 2 min read Save Anticoagulant therapy reduces risks for vision loss, stroke in giant cell arteritis Anticoagulant therapy reduces risks for vision loss, stroke in giant cell arteritis

ACCEL Lite: What Aspects of Cardiovascular Care are Most Primed for Disruption with AI?

Newsletter

Brochure

Heart and Cardiovascular Diseases

Brochure Form

November 07, 2024 2 min read Save Anticoagulant therapy reduces risks for vision loss, stroke in giant cell arteritis Anticoagulant therapy reduces risks for vision loss, stroke in giant cell arteritis

ACCEL Lite: What Aspects of Cardiovascular Care are Most Primed for Disruption with AI?